These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29880736)

  • 1.
    Li G; Cheng J; Mei S; Wu T; Ye T
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Vaccinia Virus Expressing
    Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.
    Wang X; Zhou N; Liu T; Jia X; Ye T; Chen K; Li G
    Mar Drugs; 2021 May; 19(6):. PubMed ID: 34064193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS Induced by
    Zhang Y; Zhu Y; Jiang G; Chen K; Zhang G; Chen K; Ye T; Zhou Y; Li G
    Mar Drugs; 2024 Jun; 22(7):. PubMed ID: 39057416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Vaccinia Virus Harboring
    Jiang R; Qiu Y; Zhang X; Zhou N; Jia X; Chen K; Zhou Y; Ye T; Li G
    Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic Vaccinia Virus Carrying
    Zheng X; Xu W; Ying Q; Ni J; Jia X; Zhou Y; Ye T; Li G; Chen K
    Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354990
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Li G; Mei S; Cheng J; Wu T; Luo J
    Mar Drugs; 2018 Apr; 16(5):. PubMed ID: 29701680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer.
    Zhang G; Wang Q; Yuan R; Zhang Y; Chen K; Yu J; Ye T; Jia X; Zhou Y; Li G; Chen K
    Biochem Biophys Res Commun; 2024 Oct; 730():150355. PubMed ID: 38996784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Vaccinia Virus Harboring
    Ni J; Feng H; Xu X; Liu T; Ye T; Chen K; Li G
    Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677432
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Huang F; Ma B; Wang Y; Xiao R; Kong Y; Zhou X; Xia D
    Cancer Biother Radiopharm; 2014 Dec; 29(10):403-11. PubMed ID: 25414976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
    Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
    Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.
    Breitbach CJ; Arulanandam R; De Silva N; Thorne SH; Patt R; Daneshmand M; Moon A; Ilkow C; Burke J; Hwang TH; Heo J; Cho M; Chen H; Angarita FA; Addison C; McCart JA; Bell JC; Kirn DH
    Cancer Res; 2013 Feb; 73(4):1265-75. PubMed ID: 23393196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.
    Fu X; Rivera A; Tao L; Zhang X
    Mol Ther; 2012 Oct; 20(10):1871-81. PubMed ID: 22692498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.
    Samson A; Bentham MJ; Scott K; Nuovo G; Bloy A; Appleton E; Adair RA; Dave R; Peckham-Cooper A; Toogood G; Nagamori S; Coffey M; Vile R; Harrington K; Selby P; Errington-Mais F; Melcher A; Griffin S
    Gut; 2018 Mar; 67(3):562-573. PubMed ID: 27902444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.